Bee Vectoring Technologies International Inc. — AGM Information 2020

Sep 29, 2020

BEE VECTORING TECHNOLOGIES INTERNATIONAL INC.

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

NOTICE IS HEREBY GIVEN that the Annual and Special Meeting (the “ Meeting ”) of shareholders (the “ Shareholders ”) of Bee Vectoring Technologies International Inc. (the “ Company ”) will be held at Suite 810 – 789 West Pender Street, Vancouver, BC, V6C 1H2, on Friday, the 23[rd] day of October, 2020, at the hour of 10:00 a.m. (PST) for the following purposes:

1. to receive the financial statements of the Company for the years ended September 30, 2019 and 2018 and the auditors' report thereon ;

2. to re-elect the four (4) current directors for the ensuing year;

3. to appoint auditors of the Company for the ensuing year and authorize the directors to fix their remuneration;

4. to consider, and if thought appropriate, to pass, with or without variation, an ordinary resolution (the text of which is disclosed in the Information Circular) ratifying, confirming and approving the 2020 Option Plan (as such term is defined in the Information Circular), and as more particularly described in the Information Circular;

5. to consider, and if thought appropriate, to pass, with or without variation, an ordinary resolution (the text of which is disclosed in the Information Circular) ratifying, confirming and approving the 2020 RSU Plan (as such term is defined in the Information Circular), as more particularly described in the Information Circular; and

6. to transact such further or other business as may properly come before the said meeting or any adjournment or adjournments thereof.

A copy of the Information Circular, a form of proxy, and a return envelope accompany this Notice of Meeting. A copy of the financial statements of the Company for the years ended September 30, 2019 and 2018 and the auditors' report thereon will be available for review at the Meeting and are available to the public on the SEDAR website at www.sedar.com.

The record date for the determination of shareholders entitled to receive notice of and to vote at the Meeting is September 18, 2020 (the “ Record Date ”). Shareholders of the Company whose names have been entered on the register of shareholders at the close of business on the Record Date will be entitled to receive notice of and to vote at the Meeting.

A shareholder may attend the Meeting in person or may be represented by proxy. Shareholders who are unable to attend the Meeting or any adjournment thereof in person are requested to date, sign and return the accompanying form of proxy for use at the Meeting or any adjournment thereof. To be effective, the enclosed proxy must be mailed so as to reach or be deposited with Endeavor Trust Corporation, Suite 702 – 777 Hornby Street, Vancouver, BC, V6Z 1S4, facsimile: (604) 559-8908, not later than forty-eight (48) hours (excluding Saturdays, Sundays and holidays) prior to the time set for the Meeting or any adjournment thereof.

The instrument appointing a proxy must be in writing and must be executed by the shareholder or his or her attorney authorized in writing or, if the shareholder is a corporation, under its corporate seal by an officer or attorney thereof duly authorized.

The individuals named in the enclosed form of proxy are directors and/or officers of the Company. Each shareholder has the right to appoint a proxyholder other than such individuals, who need not be a shareholder, to attend and to act for such shareholder and on such shareholder’s behalf at the Meeting. To exercise such right, the names of the nominees of management should be crossed out and the name of the shareholder’s appointee should be legibly printed in the blank space provided.

In view of the current and rapidly evolving COVID-19 outbreak, the Company asks that, in considering whether to attend the Meeting in person, shareholders follow the instructions of the Public Health Agency of Canada (https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection.html). The Company encourages Shareholders not to attend the Meeting in person if experiencing any of the described COVID-19 symptoms of fever, cough or difficulty breathing. The Company may take additional precautionary measures in relation to the Meeting in response to further developments in the COVID-19 outbreak. As always, the Company encourages shareholders to vote prior to the Meeting. Shareholders are encouraged to vote on the matters before the Meeting by proxy and to join the Meeting by teleconference. To access the Meeting by teleconference, dial toll free at 1-800-319-7310, Participation Code: 77783, followed by the # sign.

DATED this 18[th] day of September, 2020.

BY ORDER OF THE BOARD

(signed) “ Ashish Malik ” Ashish Malik, Chief Executive Officer